Zurich Cantonal Bank’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,580
| Closed | -$122K | – | 2812 |
|
|
2023
Q3 | $122K | Hold |
6,580
| – | – | ﹤0.01% | 2265 |
|
|
2023
Q2 | $72.8K | Hold |
6,580
| – | – | ﹤0.01% | 2487 |
|
|
2023
Q1 | $88.4K | Buy |
6,580
+1,127
| +21% | +$19.5K | ﹤0.01% | 2354 |
|
|
2022
Q4 | $67.5K | Buy |
5,453
+688
| +14% | +$9.74K | ﹤0.01% | 2498 |
|
|
2022
Q3 | $66K | Hold |
4,765
| – | – | ﹤0.01% | 2489 |
|
|
2022
Q2 | $66K | Sell |
4,765
-114
| -2% | -$1.82K | ﹤0.01% | 2469 |
|
|
2022
Q1 | $79K | Buy |
4,879
+1,903
| +64% | +$29.8K | ﹤0.01% | 2381 |
|
|
2021
Q4 | $48K | Hold |
2,976
| – | – | ﹤0.01% | 2755 |
|
|
2021
Q3 | $44K | Hold |
2,976
| – | – | ﹤0.01% | 2652 |
|
|
2021
Q2 | $59K | Hold |
2,976
| – | – | ﹤0.01% | 2417 |
|
|
2021
Q1 | $69K | Hold |
2,976
| – | – | ﹤0.01% | 2301 |
|
|
2020
Q4 | $74K | Hold |
2,976
| – | – | ﹤0.01% | 2324 |
|
|
2020
Q3 | $123K | Hold |
2,976
| – | – | ﹤0.01% | 1891 |
|
|
2020
Q2 | $143K | Buy |
2,976
+896
| +43% | +$69.2K | ﹤0.01% | 1754 |
|
|
2020
Q1 | $131K | Buy |
2,080
+312
| +18% | +$28K | ﹤0.01% | 1445 |
|
|
2019
Q4 | $219K | Hold |
1,768
| – | – | ﹤0.01% | 1290 |
|
|
2019
Q3 | $117K | Buy |
1,768
+539
| +44% | +$36.2K | ﹤0.01% | 1537 |
|
|
2019
Q2 | $98K | Hold |
1,229
| – | – | ﹤0.01% | 1637 |
|
|
2019
Q1 | $137K | Sell |
1,229
-187
| -13% | -$20.4K | ﹤0.01% | 1388 |
|
|
2018
Q4 | $143K | Buy |
1,416
+183
| +15% | +$19K | ﹤0.01% | 1392 |
|
|
2018
Q3 | $156K | Buy |
1,233
+179
| +17% | +$18.9K | ﹤0.01% | 1452 |
|
|
2018
Q2 | $88K | Hold |
1,054
| – | – | ﹤0.01% | 1727 |
|
|
2018
Q1 | $65K | Hold |
1,054
| – | – | ﹤0.01% | 1875 |
|
|
2017
Q4 | $62K | Buy |
1,054
+351
| +50% | +$22.1K | ﹤0.01% | 1894 |
|
|
2017
Q3 | $41K | Hold |
703
| – | – | ﹤0.01% | 1934 |
|
|
2017
Q2 | $85K | Sell |
703
-344
| -33% | -$39.8K | ﹤0.01% | 1470 |
|
|
2017
Q1 | $118K | Buy |
1,047
+132
| +14% | +$15.4K | ﹤0.01% | 1241 |
|
|
2016
Q4 | $99K | Hold |
915
| – | – | ﹤0.01% | 1304 |
|
|
2016
Q3 | $151K | Buy |
915
+370
| +68% | +$58.3K | ﹤0.01% | 1024 |
|
|
2016
Q2 | $78K | Hold |
545
| – | – | ﹤0.01% | 1285 |
|
|
2016
Q1 | $70K | Hold |
545
| – | – | ﹤0.01% | 1296 |
|
|
2015
Q4 | $81K | Buy |
545
+317
| +139% | +$53.7K | ﹤0.01% | 1232 |
|
|
2015
Q3 | $38K | Buy |
228
+178
| +356% | +$39.2K | ﹤0.01% | 1238 |
|
|
2015
Q2 | $12K | Sell |
50
-2,000
| -98% | -$533K | ﹤0.01% | 1291 |
|
|
2015
Q1 | $578K | Sell |
2,050
-1,914
| -48% | -$414K | 0.01% | 805 |
|
|
2014
Q4 | $618K | Buy |
3,964
+964
| +32% | +$178K | 0.02% | 652 |
|
|
2014
Q3 | $710K | Sell |
3,000
-1,000
| -25% | -$255K | 0.02% | 606 |
|
|
2014
Q2 | $947K | Buy |
+4,000
| New | +$1.05M | 0.03% | 574 |
|
Zurich Cantonal Bank's ICPT Position: Q4 2023 in Review
Zurich Cantonal Bank sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 6,580 shares — an estimated $122K sold.
Zurich Cantonal Bank first reported a position in ICPT in Q2 2014 and held it in 38 quarters. The position peaked at $947K in Q2 2014. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Zurich Cantonal Bank reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Zurich Cantonal Bank sold 6,580 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $122K.
- Zurich Cantonal Bank first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 38 quarters.
- Zurich Cantonal Bank's Intercept Pharmaceuticals, Inc. position peaked at $947K in Q2 2014.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Zurich Cantonal Bank's 13F filing for Q4 2023, filed 30 Jan 2024.